CAR-T therapy could “alter the treatment paradigm” of multiple sclerosis
Drug Discovery World
JANUARY 5, 2024
CAR T-cell therapy involves modifying a patient’s T cells to recognise and remove B cells in the patient’s body. KYV-101, specifically targets CD19, a protein expressed on the surface of B cells, which is involved in various types of autoimmune diseases.
Let's personalize your content